Form 4: iBio Director William D. Clark Acquires Shares in Recent Transaction
SEC Form 4
Director William D. Clark purchased 1,838 shares of iBio, Inc. common stock at a price of $2.72 per share on January 10, 2025.
Summary
- On January 10, 2025, William D. Clark, a director of iBio, Inc., acquired 1,838 shares of common stock.
- The purchase was made at a price of $2.72 per share.
- The transaction was executed pursuant to a Securities Purchase Agreement with iBio, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of a stock purchase by a director. While insider buying can be seen as a positive signal, it's a relatively small transaction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This transaction is a routine disclosure of insider trading activity, which is common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 01/10/2025 | Date of transaction: William D. Clark purchased shares of iBio, Inc. |
| 01/13/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.